Similar articles

• Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo.

  Titus JA, Perez P, Kaubisch A, Garrido MA, Segal DM. Titus JA, et al. J Immunol. 1987 Nov 1;139(9):3153-8. J Immunol. 1987. PMID: 2959724
• Heterogeneity within the population of NK and K cells.

  Jensen PJ, Koren HS. Jensen PJ, et al. J Immunol. 1980 Jan;124(1):395-8. J Immunol. 1980. PMID: 6985645
• A subset of CD16-natural killer cells without antibody-dependent cellular cytotoxicity function.

  Schubert J, Heiken H, Jacobs R, Delany P, Witte T, Schmidt RE. Schubert J, et al. Nat Immun Cell Growth Regul. 1990;9(2):103-11. Nat Immun Cell Growth Regul. 1990. PMID: 2141105
• Natural killer cells--toward clinical application.

  Schattner A, Duggan DB. Schattner A, et al. Am J Hematol. 1985 Apr;18(4):435-43. doi: 10.1002/ajh.2830180415. Am J Hematol. 1985. PMID: 2579549 Review.
• Receptors for the Fc fragment of IgG on natural killer cells.

  Trinchieri G, Valiante N. Trinchieri G, et al. Nat Immun. 1993 Jul-Oct;12(4-5):218-34. Nat Immun. 1993. PMID: 8257828 Review.